CNTX
Context Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$127.71M
P/E Ratio
—
EPS
$-0.42
Beta
1.61
52W High
$3.62
52W Low
$0.56
50-Day MA
$2.33
200-Day MA
$1.79
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Context Therapeutics Inc
Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of chronic pain. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-43.50M |
| Operating Margin | 0.00% |
| Return on Equity | -56.20% |
| Return on Assets | -35.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.57 |
| Price-to-Book | 2.45 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $91.88M |
| Float | $42.82M |
| % Insiders | 1.25% |
| % Institutions | 81.31% |
Historical Volatility
HV 10-Day
100.84%
HV 20-Day
121.55%
HV 30-Day
104.77%
HV 60-Day
95.12%
HV Rank
95.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($6.00 target)
3
Strong Buy6
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026